Analyst Recommendations

Wells Fargo analyst issues BUY recommendation for NVDA on February 5, 2024 07:00AM ET. The previous analyst recommendation was Buy.NVDA was trading at $661.6 at issue of the...

February 5, 2024   NVDA 1.14%

Goldman Sachs analyst issues OUTPERFORM recommendation for AAPL on February 2, 2024 11:33AM ET. The previous analyst recommendation was Buy.AAPL was trading at $186.28 at issue of the...

February 2, 2024   AAPL -0.98%

Needham analyst issues BUY recommendation for AMZN on February 2, 2024 11:10AM ET. The previous analyst recommendation was Buy.AMZN was trading at $171.06 at issue of the analyst...

February 2, 2024   AMZN -0.89%

KeyBanc analyst issues OVERWEIGHT recommendation for META on February 2, 2024 05:46AM ET. The previous analyst recommendation was Overweight.META was trading at $394.78 at issue of the analyst...

February 2, 2024   META -0.55%

BMO Capital analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 2, 2024   MA 0.08%

Scotiabank analyst issues PERFORM recommendation for CVX on February 2, 2024 01:06AM ET. The previous analyst recommendation was Sector Outperform.CVX was trading at $147.89 at issue of the...

February 2, 2024   CVX -0.30%

Raymond James analyst issues OUTPERFORM recommendation for CVX on February 2, 2024 01:06AM ET. The previous analyst recommendation was Outperform.CVX was trading at $147.89 at issue of the...

February 2, 2024   CVX -0.30%

Raymond James analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 2, 2024   MA 0.08%

Raymond James analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 2, 2024   MA 0.08%

BMO Capital analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 2, 2024   MA 0.08%